[{"orgOrder":0,"company":"Medibiofarma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"SPAIN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"MBF-118","moa":"Undisclosed","graph1":"Immunology","graph2":"Phase II","graph3":"Medibiofarma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Medibiofarma \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Medibiofarma \/ Inapplicable"},{"orgOrder":0,"company":"Medibiofarma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SPAIN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"MBF-015","moa":"Undisclosed","graph1":"Genetic Disease","graph2":"Phase II","graph3":"Medibiofarma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Medibiofarma \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Medibiofarma \/ Inapplicable"},{"orgOrder":0,"company":"Medibiofarma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SPAIN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"MBF-118","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I","graph3":"Medibiofarma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Medibiofarma \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Medibiofarma \/ Inapplicable"},{"orgOrder":0,"company":"Medibiofarma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SPAIN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"MBF-362","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I","graph3":"Medibiofarma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Medibiofarma \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Medibiofarma \/ Inapplicable"},{"orgOrder":0,"company":"Medibiofarma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SPAIN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"MBF-015","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Medibiofarma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Medibiofarma \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Medibiofarma \/ Inapplicable"}]